Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial-Reference-Cited by-同舟云学术

Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Published:2017-05 Issue:5 Volume:17 Page:528-537
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Huttner Angela,Hatz Christoph,van den Dobbelsteen Germie,Abbanat Darren,Hornacek Alena,Frölich Rahel,Dreyer Anita M,Martin Patricia,Davies Todd,Fae Kellen,van den Nieuwenhof Ingrid,Thoelen Stefan,de Vallière Serge,Kuhn Anette,Bernasconi Enos,Viereck Volker,Kavvadias Tilemachos,Kling Kerstin,Ryu Gloria,Hülder Tanja,Gröger Sabine,Scheiner David,Alaimo Cristina,Harbarth Stephan,Poolman Jan,Fonck Veronica Gambillara

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Population-based epidemiology and microbiology of community-onset bloodstream infections;Laupland;Clin Microbiol Rev,2014

2. Urinary tract infections: epidemiology, mechanisms of infection and treatment options;Flores-Mireles;Nat Rev Microbiol,2015

3. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014;Weiner;Infect Control Hosp Epidemiol,2016

4. The health and economic burden of bloodstream infections caused by antimicrobial susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals: a multicentre retrospective cohort study;Stewardson;Eurosurveillance,2016

5. 10 × '20 progress—development of new drugs active against gram-negative bacilli. An update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2013

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics;Nature Reviews Microbiology;2024-09-09

2. Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60 to 85 years in a randomized, double-blind, phase 1 study.;Journal of Infection and Chemotherapy;2024-09

3. Characterization of Turbo, a TLR Ligand-based Adjuvant for Glycoconjugate Vaccines;ImmunoHorizons;2024-08-01

4. Recent Insights into the Synthesis of Oligosaccharides from Escherichia coli: Review;Current Organic Chemistry;2024-07-18

5. A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI;npj Vaccines;2024-06-14